An observational study in Diabetes Mellitus and Diabetic Nephropathy, sponsored by AHEPA University Hospital. Status unknown at 1 site in Greece. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2015-04-21.
Sponsored by AHEPA University Hospital · Observational
The purpose of the present study is to evaluate bias, precision and accuracy of new cystatin C and creatinine based equations for GFR estimation compared with 51Cr-EDTA (chromium-51 labeled ethylenediamine tetraacetic acid) measured GFR in patients with diabetes.
The purpose of the present study is to evaluate bias, precision and accuracy of new cystatin C and creatinine based equations for GFR estimation compared with 51Cr-EDTA measured GFR in patients with diabetes.
Additional, we will check which equation detects better the reduction of renal function over the time, in patients with diabetes.
Finally, we will investigate if cystatin C levels can be influenced by factors other than GFR
534 studies on the registry are indexed under Diabetic Nephropathies; 107 are open to participants now.
This study's planned enrollment of 600 is above the median of 154 across 142 observational studies indexed under Diabetic Nephropathies.
Browse Diabetic Nephropathies studies →AHEPA University Hospital is the lead sponsor of 34 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
diabetic patients treated in the primary care clinic
Exclusion Criteria:
This study is status unknown, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
AHEPA University Hospital